Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(3aS,8aR)-2-(6-methylpyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole, also known as TAK-981, is a novel heterocyclic compound with potential therapeutic applications. It belongs to the oxazole class of compounds and contains a fused indeno-oxazole ring system. TAK-981 is being studied for its potential use in the treatment of various diseases, including cancer and autoimmune disorders. Its unique chemical structure and potential pharmacological properties make it an interesting candidate for further research and development in the field of medicinal chemistry.

2757082-99-6

Post Buying Request

2757082-99-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 2-[(3aR,8aS)-3aH,8H,8aH-indeno[1,2-d][1,3]oxazol-2-yl]-6-methylpyridine

    Cas No: 2757082-99-6

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier

2757082-99-6 Usage

Uses

Used in Pharmaceutical Industry:
TAK-981 is used as a potential therapeutic agent for the treatment of various diseases, including cancer and autoimmune disorders, due to its unique chemical structure and potential pharmacological properties.
Used in Medicinal Chemistry Research:
TAK-981 is used as a promising candidate for further research and development in the field of medicinal chemistry, given its potential therapeutic applications and interesting chemical properties.

Check Digit Verification of cas no

The CAS Registry Mumber 2757082-99-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 2,7,5,7,0,8 and 2 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 2757082-99:
(9*2)+(8*7)+(7*5)+(6*7)+(5*0)+(4*8)+(3*2)+(2*9)+(1*9)=216
216 % 10 = 6
So 2757082-99-6 is a valid CAS Registry Number.

2757082-99-6Downstream Products

2757082-99-6Relevant articles and documents

Chiral Alkyl Amine Synthesis via Catalytic Enantioselective Hydroalkylation of Enecarbamates

Qian, Deyun,Bera, Srikrishna,Hu, Xile

supporting information, p. 1959 - 1967 (2021/02/06)

Chiral alkyl amines are omnipresent as bioactive molecules and synthetic intermediates. The catalytic and enantioselective synthesis of alkyl amines from readily accessible precursors is challenging. Here we develop a nickel-catalyzed hydroalkylation method to assemble a wide range of chiral alkyl amines from enecarbamates (N-Cbz-protected enamines) and alkyl halides with high regio- and enantioselectivity. The method works for both nonactivated and activated alkyl halides and is able to produce enantiomerically enriched amines with two minimally differentiated α-alkyl substituents. The mild conditions lead to high functional group tolerance, which is demonstrated in the postproduct functionalization of many natural products and drug molecules, as well as the synthesis of chiral building blocks and key intermediates to bioactive compounds.

Enantioselective Ni-Catalyzed Electrochemical Synthesis of Biaryl Atropisomers

Chen, Song,Chen, Yue-Gang,Gao, Pei-Sen,Liu, Dong,Ma, Hong-Xing,Mei, Tian-Sheng,Qiu, Hui,Shuai, Bin,Wang, Yun-Zhao

supporting information, p. 9872 - 9878 (2020/06/27)

A scalable enantioselective nickel-catalyzed electrochemical reductive homocoupling of aryl bromides has been developed, affording enantioenriched axially chiral biaryls in good yield under mild conditions using electricity as a reductant in an undivided cell. Common metal reductants such as Mn or Zn powder resulted in significantly lower yields in the absence of electric current under otherwise identical conditions, underscoring the enhanced reactivity provided by the combination of transition metal catalysis and electrochemistry.

Ligand-Controlled Regiodivergent Hydroalkylation of Pyrrolines

Qian, Deyun,Hu, Xile

supporting information, p. 18519 - 18523 (2019/11/22)

Nickel hydride (NiH) catalyzed hydrocarbonation has emerged as an efficient approach to construct new C?C bonds containing at least one C(sp3) center. However, the regioselectivity of this reaction is by far dictated by substrates. Described here is a strategy to achieve two different regioselectivites of hydroalkylation of the same substrates by using ligand control. This strategy enables the first regiodivergent hydroalkylation of 3-pyrrolines, yielding both 2- and 3-alkylated pyrrolidines, valuable synthetic intermediates and common motifs in many bioactive molecules. This method demonstrates broad scope and high functional-group tolerance, and can be applied in late-stage functionalizations.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2757082-99-6